Literature DB >> 20380779

A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis.

P Sørensen1, M Birket-Smith, U Wattar, I Buemann, P Salkovskis.   

Abstract

BACKGROUND: Hypochondriasis is common in the clinic and in the community. Cognitive behavioural therapy (CBT) has been found to be effective in previous trials. Psychodynamic psychotherapy is a treatment routinely offered to patients with hypochondriasis in many countries, including Denmark. The aim of this study was to test CBT for hypochondriasis in a centre that was not involved in its development and compare both CBT and short-term psychodynamic psychotherapy (STPP) to a waiting-list control and to each other. CBT was modified by including mindfulness and group therapy sessions, reducing the therapist time required. STPP consisted of individual sessions.
METHOD: Eighty patients randomized to CBT, STPP and the waiting list were assessed on measures of health anxiety and general psychopathology before and after a 6-month treatment period. Waiting-list patients were subsequently offered one of the two active treatments on the basis of re-randomization, and assessed on the same measures post-treatment. Patients were again assessed at 6- and 12-month follow-up points.
RESULTS: Patients who received CBT did significantly better on all measures relative to the waiting-list control group, and on a specific measure of health anxiety compared with STPP. The STPP group did not significantly differ from the waiting-list group on any outcome measures. Similar differences were observed between CBT and STPP during follow-up, although some of the significant differences between groups were lost.
CONCLUSIONS: A modified and time-saving CBT programme is effective in the treatment of hypochondriasis, although the two psychotherapeutic interventions differed in structure.

Entities:  

Mesh:

Year:  2010        PMID: 20380779     DOI: 10.1017/S0033291710000292

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  10 in total

1.  [Psychodynamic therapy of depression].

Authors:  F Leichsenring; S Rabung
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

2.  A standard for test reliability in group research.

Authors:  Jules L Ellis
Journal:  Behav Res Methods       Date:  2013-03

3.  [Psychotherapeutic approaches for patients with somatoform disorders].

Authors:  J M Gottschalk; W Rief
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

4.  A randomized trial of treatments for high-utilizing somatizing patients.

Authors:  Arthur J Barsky; David K Ahern; Mark R Bauer; Nyryan Nolido; E John Orav
Journal:  J Gen Intern Med       Date:  2013-03-14       Impact factor: 5.128

5.  Treatment of mental hypochondriasis: a case report.

Authors:  Florian Weck
Journal:  Psychiatr Q       Date:  2014-03

Review 6.  Recent Advances in the Understanding and Treatment of Health Anxiety.

Authors:  Peter Tyrer
Journal:  Curr Psychiatry Rep       Date:  2018-06-22       Impact factor: 5.285

7.  Mindfulness-Based Cognitive Therapy (MBCT) for Health Anxiety (Hypochondriasis): Rationale, Implementation and Case Illustration.

Authors:  Christina Surawy; Freda McManus; Kate Muse; J Mark G Williams
Journal:  Mindfulness (N Y)       Date:  2015

8.  Pilot trial of a therapist-supported internet-delivered cognitive behavioural therapy program for health anxiety.

Authors:  Jill M Newby; Alison E J Mahoney; Elizabeth C Mason; Jessica Smith; Shivani Uppal; Gavin Andrews
Journal:  Internet Interv       Date:  2016-10-02

9.  Hypochondriacal attitudes comprise heterogeneous non-illness-related cognitions.

Authors:  Michael Schwenzer; Klaus Mathiak
Journal:  BMC Psychiatry       Date:  2012-10-17       Impact factor: 3.630

10.  Traditional Meditation, Mindfulness and Psychodynamic Approach: An Integrative Perspective.

Authors:  Simone Bianco; Paolo Barilaro; Arianna Palmieri
Journal:  Front Psychol       Date:  2016-04-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.